Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease

Brain Research

Volumn 1233, Issue , 2008, Pages 196-202

  Chen, Yan ^a,b   Jia, Longfei ^a,b   Wei, Cuibai ^a,b   Wang, Fen ^a,b   Lv, Haiyan ^a,b   Jia, Jianping ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Apolipoprotein D gene; Linkage disequilibrium; Single nucleotide polymorphism; Sporadic Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN D;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; HAPLOTYPE; HUMAN; INTRON; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS D; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SEX FACTORS;

EID: 51449091592     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.018     Document Type: Article

References (37)

1. Belloir B., Kövari E., Surini-Demiri M., and Savioz A. Altered apolipoprotein D expression in the brain of patients with Alzheimer disease. J. Neurosci. 64 (2001) 61-69 (PubMed: 11276052)
2. Boyles J.K., Notterpek L.M., and Anderson L.J. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve: identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J. Biol. Chem. 265 (1990) 17805-17815 (PubMed: 2120218)
3. Boxer L.M., Prywes R., Roeder R.G., and Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol. Cell. Biol. 9 (1989) 515-522 (PubMed: 2710114)
4. Connor J.R., Milward E.A., Moalem S., Sampietro M., Boyer P., Percy M.E., Vergani C., Scott R.J., and Chorney M. Is hemochromatosis a risk factor for Alzheimer's disease?. J Alzheimer's Dis. 3 (2001) 471-477 (PubMed: 12214033)
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923 (PubMed: 8346443)
6. Desai P.P., Ikonomovic M.D., Abrahamson E.E., Hamilton R.L., Isanski B.A., Hope C.E., Klunk W.E., DeKosky S.T., and Kamboh M.I. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol. Dis. 20 (2005) 574-582 (PubMed: 15916898)
7. Desai P.P., Hendrie H.C., Evans R.M., Murrell J.R., DeKosky S.T., and Kamboh M.I. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am. J. Med. Genet., B 116B (2003) 98-101 (PubMed: 12497622)
8. Dilley W.G., Haagensen D.E., Cox C.E., and Wells Jr. S.A. Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid. Breast Cancer Res. Treat. 16 (1990) 253-260 (PubMed: 2085676)
9. Drayna D.T., McLean J.W., Wion K.L., Trent J.M., Drabkin H.A., and Lawn R.M. Human apolipoprotein D gene: gene sequence, chromosomal localization, and homology to the 2m-globulin superfamily. DNA 6 (1987) 199-204 (PubMed: 2439269)
10. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356 (PubMed: 9343467)
11. Glockner F., and Ohm T.G. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience 122 (2003) 103-110 (PubMed: 14596852)
12. Goodrum J.F. Cholesterol synthesis in regenerating peripheral nerve is not influenced by serum cholesterol levels. J. Neurochem. 60 4 (1993 Apr) 1564-1566 PMID: (PubMed: 8455042)
13. Helisalmi S., Hiltunen M., Vepsäläinen S., Iivonen S., Corder E.H., Lehtovirta M., Mannermaa A., Koivisto A.M., and Soininen H. Genetic variation in apolipoprotein D and Alzheimer's disease. J. Neurol. 251 (2004) 951-957 (PubMed: 15316799)
14. Hiltunen M., Mannermaa A., Thompson D., Easton D., Pirskanen M., Helisalmi S., Koivisto A.M., Lehtovirta M., Ryynänen M., and Soininen H. Genomewide linkage disequilibrium mapping of late-onset Alzheimer disease in Finland. Neurology 57 (2001) 1663-1668 (PubMed: 11706108)
15. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548 (PubMed: 2341813)
16. Holtzman D.M. Role of apoe/Ab interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17 (2001) 147-155 (PubMed: 11816788)
17. Hu Z.Y., Bourreau E., Jung-Testas I., Robel P., and Baulieu E.E. Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 8215-8219 (PubMed: 3479785)
18. Kalman J., McConathy W., Araoz C., Kasa P., and Lacko A.G. Apolipoprotein D in aging brain and in Alzheimer's dementia. Neurol. Res. 22 (2000) 330-336 (PubMed: 10874678)
19. Khan M.M., Parikh V.V., and Mahadik S.P. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J. Neurochem. 86 (2003) 1089-1100 (PubMed: 12911617)
20. Lambert J., Provost P.R., Marcel Y.L., and Rassart E. Structure of the human apolipoprotein D gene promoter region. Biochim. Biophys. Acta 1172 (1993) 190-192 (PubMed: 7916629)
21. Lea O.A. Binding properties of progesterone-binding Cyst protein, PBCP. Steroids 52 (1988) 337-338 (PubMed: 3250014)
22. McEwen B.S., and Woolley C.S. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp. Gerontol. 29 (1994) 431-436 [PubMed: 7925761]
23. Morais Cabral J.H., Atkins G.L., Sánchez L.M., López-Boado Y.S., López-Otin C., and Sawyer L. Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett. 366 (1995) 53-56 (PubMed: 7789516)
24. Navarro A., Del Valle E., Astudillo A., González del Rey C., and Tolivia J. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp. Neurol. 184 (2003) 697-704 (PubMed: 14769361)
25. Patel R.C., Lange D., McConathy W.J., Patel Y.C., and Patel S.C. Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy. Protein Eng. 10 (1997) 621-625 (PubMed: 9278274)
26. Pearlman W.H., Gueriguian J.L., and Sawyer M.E. A specific progesterone-binding component of human breast cyst fluid. J. Biol. Chem. 248 (1973) 5736-5741 (PubMed: 4723913)
27. Rassart E., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L., and Milne R. Apolipoprotein D. Biochim. Biophys. Acta 1482 (2000) 185-198 (PubMed: 11058760)
28. Rubinsztein D.C., and Easton D.F. Apolipoprotein E genetic variation and Alzheimer disease: a meta-analysis. Dement. Geriatr. Cogn. Disord. 10 (1999) 199-209 (PubMed: 10325447)
29. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98 (PubMed: 15740637)
30. Simard J., Veilleux R., de Launoit Y., Haagensen D.E., and Labrie F. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer 51 (1991) 4336-4341 (PubMed: 1868457)
31. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R., and Rassart E. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer patients. J. Neurochem. 71 (1998) 1643-1650 (PubMed: 9751198)
32. Terrisse L., Séguin D., Bertrand P., Poirier J., Milne R., and Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Mol. Brain Res. 70 (1999) 26-35 (PubMed: 10381540)
33. Thomas E.A., Sautkulis L.N., Criado J.R., Games D., and Sutcliffe J.G. Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice. J. Neurochem. 79 (2001) 1059-1064 (PubMed: 11739619)
34. Thomas E.A., Laws S.M., Sutcliffe J.G., Harper C., Dean B., McClean C., Masters C., Lautenschlager N., Gandy S.E., and Martins R.N. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol. Psychiatry 54 (2003) 136-141 (PubMed: 12873803)
35. Vogt M., and Skerra A. Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin or E-3M2H. J. Mol. Recogn. 14 (2001) 79-86 (PubMed: 11180564)
36. Ward R.J., Zhang Y., and Crichton R.R. Aluminium toxicity and iron homeostasis. J. Inorg. Biochem. 87 (2001) 9-14 (PubMed: 11709207)
37. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 5 (1996) 921-932 (PubMed: 8630250)